Clinical trial
Use of Biodesign® Otologic Graft in Tympanoplasty: A Prospective, Randomized Trial
NCT03904316 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Biodesign® Otologic Graft in Tympanoplasty: A Prospective, Randomized Trial
- Lead sponsor
- Henry Ford Health System
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- October 3, 2018
- Completion date
- July 1, 2022
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.